A research study co-authored by Florida Cancer Specialists & Research Institute (FCS) physicians and senior leaders will be ...

Saeed Sadeghi, MD, discusses the findings on transfusion independence achieved with treatment for patients with low-risk ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

Anemia remains a major public health concern in India, affecting women, children and pregnant mothers, leading to severe ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Geron Corp's Rytelo launch & robust pipeline offer a compelling investment opportunity, despite stock challenges. Click here ...

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

The MoHFW’s AI push spans multiple domains of public health, from infectious disease surveillance to telemedicine, ...

Media Disease Surveillance' (MDS) is an AI-driven tool that has been supporting event-based surveillance for infectious ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second ...

Increased mixed chimerism, as detected by AlloHeme, could predict post-transplant relapse “with a high degree of accuracy,” said Monzr M. Al Malki, MD.